Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × Radiotherapy, Intensity-Modulated × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 29 Head and Neck Neoplasms 23 Prostatic Neoplasms 14 Oropharyngeal Neoplasms 10 Carcinoma, Non-Small-Cell Lung 8 Uterine Cervical Neoplasms 7 Gliosarcoma 7 Glioblastoma 7 Brain Neoplasms 7 Rectal Neoplasms 6 Carcinoma, Squamous Cell 6 Lung Neoplasms 5 Tongue Neoplasms 4 Papillomavirus Infections 4 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Mouth Neoplasms 4 Laryngeal Neoplasms 4 Astrocytoma 4 Sarcoma 3 Glioma 3 Carcinoma 3 Urinary Bladder Neoplasms 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neuroblastoma 2 Neoplasms 2 Mesothelioma, Malignant 2 Leukemia 2

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡